pelabresib

Novartis may have bought MorphoSys, but it really only had eyes for BET inhibitor pelabresib: filing
Fierce Biotech
Fri, 04/12/24 - 11:23 am
Novartis
MorphoSys
pelabresib
myelofibrosis
M&A
BET inhibitor
MorphoSys’ pelabresib meets endpoints in Phase III myelofibrosis trial
Clinical Trials Arena
Tue, 11/21/23 - 11:55 am
MorphoSys
clinical trials
pelabresib
myelofibrosis